Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2/3 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 23Thoracic 14Breast 12Genitourinary 9CNS 9Tumor-Agnostic 6Gynecologic 4Other hematologic neoplasm 3Lymphoid 3Endocrine 3Head & Neck 2Dermatologic 2Other neoplasm 1Other 1

Conditions

Leukemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Emergence Delirium 1

Interventions

Cytarabine 905Cyclophosphamide 899fludarabine 525venetoclax 489fludarabine phosphate 468Azacitidine 460Rituximab 431Methotrexate 419Etoposide 320Filgrastim 299Busulfan 296Dexamethasone 286Vincristine 285Daunorubicin 283Peripheral Blood Stem Cell Transplantation 258Whole-Body Irradiation 243Mycophenolic Acid 232Decitabine 230Granulocyte Colony-Stimulating Factor 227Tacrolimus 220Imatinib Mesylate 211Idarubicin 205Melphalan 202Cyclosporine 182Doxorubicin 177Radiotherapy 169Prednisone 164Dasatinib 163Mitoxantrone 161Lenalidomide 160

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Propofol × Other hematologic neoplasm × Clear all
NCT03528954 2019-02-06

Propofol to Reduce the Incidence of Postanesthetic Emergence Agitation in Pediatric Patients Under General Anesthesia

Indonesia University

Phase NA Completed
54 enrolled
LymphoidOther hematologic neoplasm

Emergence Delirium, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00214370 2015-10-05

Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma

University of Wisconsin, Madison

Phase NA Completed
40 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT01326078 2014-03-26

Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures.

CristĂĄlia Produtos QuĂ­micos FarmacĂȘuticos Ltda.

Phase 2/3 Withdrawn
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡